ArticleScientific reports2026
Advanced analysis and detection of cervical cancer using NASNetLarge.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer detection plays an pivotal role in healthcare sector. While usage of methods like visual inspection and manual examination often leads to human inaccuracy. Proposed study makes use of NASNetLarge aiming to enhance diagnostic accuracy and efficiency to tackle these challenges. Data augmentation techniques were used for a smooth training process, of the training data, extensive data augmentation techniques were employed. Using Keras, which is a Python library based on TensorFlow 2.8.2, the study implemented transfer learning which allowed the model to take advantage of NASNetLarge model’s feature extraction capabilities. The top layers of the NASNetLarge model trained on the ImageNet dataset originally, were upgraded to layers tailored for the specific classification task. Adam optimizer was used for training the model with a learning rate of 0.0001 for 27 epochs with a batch size of 8 achieving a remarkable training accuracy of 94% demonstrating its potential for aiding in the clinical diagnosis of cervical cancer. The performance of the model was evaluated on a validation set. Overall the model resulted in an accuracy of 98.33%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.